Outcomes of Drug Resistant Epileptic Pediatric Patient by Modified Atkins Diet
NCT ID: NCT07275125
Last Updated: 2025-12-10
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
40 participants
OBSERVATIONAL
2025-12-30
2026-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
1. Control of seizures(frequency , duration and numbers of hospital admissions) .
2. Quality of life by pediatric quality of life inventory v4.
3. Cognitive function by stanford binet intelligence scale 5th edition.
4. Growth parameters ( weight, height will be combined to report BMI in kg/m\^2).
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Modified Atkins Diet in Children and Adolescents With Drug-resistant Epilepsy
NCT01278966
Modified Atkins Diet Versus Levetiracetam for Refractory Childhood Epilepsy
NCT04172311
Use of the Atkins Diet for Children With Intractable Epilepsy: A Comparison of Daily Carbohydrate Limits
NCT00181090
Dietary Therapy in Children With Refractory Epilepsy
NCT01983163
Effect of Magnesium Supplementation for Children With Drug Resistant Idiopathic Epilepsy
NCT02982824
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
CROSS_SECTIONAL
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Diagnosed with drug-resistant epilepsy according to ILAE definition.\[2\]
* On KD for at least 6 months.
Exclusion Criteria
* Non-compliance with KD .
Patients on alternative dietary therapies (e.g., low glycemic diet)
1 Year
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Sohag University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Mahmoud Saber Elsayed
Resident
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Sohag faculty of medicine
Sohag, , Egypt
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Soh-med-25-9-IMS
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.